 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its commercial and development portfolio will be presented at the American...

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference

United Therapeutics Co. (NASDAQ:UTHR - Get Free Report) CEO Martine A. Rothblatt sold 15,000 shares of the company's stock in a transaction that occurred on Thursday, April 4th. The shares were sold...

Martine A. Rothblatt Sells 15,000 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock

Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ...

StockNews.com upgraded shares of United Therapeutics (NASDAQ:UTHR - Free Report) from a buy rating to a strong-buy rating in a research note released on Wednesday.
A number of other equities research...

United Therapeutics (NASDAQ:UTHR) Upgraded to "Strong-Buy" at StockNews.com

United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 30,000 Shares

First Citizens Bank & Trust Co. acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the...

First Citizens Bank & Trust Co. Buys Shares of 1,910 United Therapeutics Co. (NASDAQ:UTHR)

United Therapeutics motion for restraining order over Liquidia's Yutrepia denied...

United Therapeutics motion for restraining order over Liquidia's Yutrepia denied

United Therapeutics Co. (NASDAQ:UTHR - Get Free Report) Director Nilda Mesa sold 325 shares of the company's stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an...

Nilda Mesa Sells 325 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock

United Therapeutics Co. (NASDAQ:UTHR - Get Free Report) Director Nilda Mesa sold 325 shares of the company's stock in a transaction dated Wednesday, March 27th. The shares were sold at an average...

Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) Director Sells 325 Shares of Stock

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Volume (M)	275,926.00
52-Wk High	$261.54
52-Wk Low	$204.44

UTHR United Therapeutics Corp

About

Feed

News

Sentiment

Earnings

Fundamentals